Tesaro, Inc.
Records under this name other than the patents Tesaro, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,091,459 | Niraparib Compositions now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 11,673,877 | Niraparib Compositions now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| 14/357,884 | Modulating Certain Tyrosine Kinases Abandoned Abandoned Mar 16, 2016 | Abandoned | Abandoned Mar 16, 2016 | |
| 14/962,588 | Methods and Materials for Predicting Response to Niraparib held by Myriad Genetics, Inc. Abandoned Abandoned Sep 11, 2018 | Abandoned | Abandoned Sep 11, 2018 | |
| 16/346,463 | Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3) Abandoned Abandoned Dec 20, 2021 | Abandoned | Abandoned Dec 20, 2021 | |
| 16/584,149 | Niraparib Formulations Abandoned Abandoned Nov 24, 2020 | Abandoned | Abandoned Nov 24, 2020 | |
| 16/608,111 | Antibody Agents Directed Against Lymphocyte Activation GENE-3 (LAG-3) and Uses Thereof now held by Anaptysbio, Inc. Abandoned Abandoned Apr 6, 2023 | Abandoned | Abandoned Apr 6, 2023 | |
| 16/958,646 | Methods of Treating Cancer Abandoned Abandoned Nov 29, 2024 | Abandoned | Abandoned Nov 29, 2024 | |
| 16/967,351 | Pediatric Niraparib Formulations and Pediatric Treatment Methods Abandoned Abandoned Mar 22, 2024 | Abandoned | Abandoned Mar 22, 2024 | |
| 17/073,198 | Niraparib Formulations Abandoned Abandoned Jan 28, 2023 | Abandoned | Abandoned Jan 28, 2023 |